Literature DB >> 32956347

Leveraging correlations between variants in polygenic risk scores to detect heterogeneity in GWAS cohorts.

Jie Yuan1, Henry Xing1, Alexandre Louis Lamy1, Todd Lencz2, Itsik Pe'er1.   

Abstract

Evidence from both GWAS and clinical observation has suggested that certain psychiatric, metabolic, and autoimmune diseases are heterogeneous, comprising multiple subtypes with distinct genomic etiologies and Polygenic Risk Scores (PRS). However, the presence of subtypes within many phenotypes is frequently unknown. We present CLiP (Correlated Liability Predictors), a method to detect heterogeneity in single GWAS cohorts. CLiP calculates a weighted sum of correlations between SNPs contributing to a PRS on the case/control liability scale. We demonstrate mathematically and through simulation that among i.i.d. homogeneous cases generated by a liability threshold model, significant anti-correlations are expected between otherwise independent predictors due to ascertainment on the hidden liability score. In the presence of heterogeneity from distinct etiologies, confounding by covariates, or mislabeling, these correlation patterns are altered predictably. We further extend our method to two additional association study designs: CLiP-X for quantitative predictors in applications such as transcriptome-wide association, and CLiP-Y for quantitative phenotypes, where there is no clear distinction between cases and controls. Through simulations, we demonstrate that CLiP and its extensions reliably distinguish between homogeneous and heterogeneous cohorts when the PRS explains as low as 3% of variance on the liability scale and cohorts comprise 50, 000 - 100, 000 samples, an increasingly practical size for modern GWAS. We apply CLiP to heterogeneity detection in schizophrenia cohorts totaling > 50, 000 cases and controls collected by the Psychiatric Genomics Consortium. We observe significant heterogeneity in mega-analysis of the combined PGC data (p-value 8.54 × 0-4), as well as in individual cohorts meta-analyzed using Fisher's method (p-value 0.03), based on significantly associated variants. We also apply CLiP-Y to detect heterogeneity in neuroticism in over 10, 000 individuals from the UK Biobank and detect heterogeneity with a p-value of 1.68 × 10-9. Scores were not significantly reduced when partitioning by known subclusters ("Depression" and "Worry"), suggesting that these factors are not the primary source of observed heterogeneity.

Entities:  

Mesh:

Year:  2020        PMID: 32956347      PMCID: PMC7529195          DOI: 10.1371/journal.pgen.1009015

Source DB:  PubMed          Journal:  PLoS Genet        ISSN: 1553-7390            Impact factor:   5.917


  47 in total

1.  Integrating Gene Expression with Summary Association Statistics to Identify Genes Associated with 30 Complex Traits.

Authors:  Nicholas Mancuso; Huwenbo Shi; Pagé Goddard; Gleb Kichaev; Alexander Gusev; Bogdan Pasaniuc
Journal:  Am J Hum Genet       Date:  2017-02-23       Impact factor: 11.025

Review 2.  Concepts and Misconceptions about the Polygenic Additive Model Applied to Disease.

Authors:  Peter M Visscher; Naomi R Wray
Journal:  Hum Hered       Date:  2016-09-01       Impact factor: 0.444

3.  Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes.

Authors: 
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

4.  Genome-wide association studies in systemic lupus erythematosus: a perspective.

Authors:  Deborah S Cunninghame Graham
Journal:  Arthritis Res Ther       Date:  2009-07-09       Impact factor: 5.156

5.  UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.

Authors:  Cathie Sudlow; John Gallacher; Naomi Allen; Valerie Beral; Paul Burton; John Danesh; Paul Downey; Paul Elliott; Jane Green; Martin Landray; Bette Liu; Paul Matthews; Giok Ong; Jill Pell; Alan Silman; Alan Young; Tim Sprosen; Tim Peakman; Rory Collins
Journal:  PLoS Med       Date:  2015-03-31       Impact factor: 11.069

6.  Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder.

Authors:  Todd Lencz; Saurav Guha; Chunyu Liu; Jeffrey Rosenfeld; Semanti Mukherjee; Pamela DeRosse; Majnu John; Lijun Cheng; Chunling Zhang; Judith A Badner; Masashi Ikeda; Nakao Iwata; Sven Cichon; Marcella Rietschel; Markus M Nöthen; A T A Cheng; Colin Hodgkinson; Qiaoping Yuan; John M Kane; Annette T Lee; Anne Pisanté; Peter K Gregersen; Itsik Pe'er; Anil K Malhotra; David Goldman; Ariel Darvasi
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Genetic pleiotropy in complex traits and diseases: implications for genomic medicine.

Authors:  Jacob Gratten; Peter M Visscher
Journal:  Genome Med       Date:  2016-07-19       Impact factor: 11.117

8.  Comparison and assessment of family- and population-based genotype imputation methods in large pedigrees.

Authors:  Ehsan Ullah; Raghvendra Mall; Mostafa M Abbas; Khalid Kunji; Alejandro Q Nato; Halima Bensmail; Ellen M Wijsman; Mohamad Saad
Journal:  Genome Res       Date:  2018-12-04       Impact factor: 9.043

9.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.

Authors:  Shaun M Purcell; Naomi R Wray; Jennifer L Stone; Peter M Visscher; Michael C O'Donovan; Patrick F Sullivan; Pamela Sklar
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

10.  A method to decipher pleiotropy by detecting underlying heterogeneity driven by hidden subgroups applied to autoimmune and neuropsychiatric diseases.

Authors:  Buhm Han; Jennie G Pouget; Kamil Slowikowski; Eli Stahl; Cue Hyunkyu Lee; Dorothee Diogo; Xinli Hu; Yu Rang Park; Eunji Kim; Peter K Gregersen; Solbritt Rantapää Dahlqvist; Jane Worthington; Javier Martin; Steve Eyre; Lars Klareskog; Tom Huizinga; Wei-Min Chen; Suna Onengut-Gumuscu; Stephen S Rich; Naomi R Wray; Soumya Raychaudhuri
Journal:  Nat Genet       Date:  2016-05-16       Impact factor: 38.330

View more
  1 in total

1.  Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.

Authors:  Antonio F Pardiñas; Sophie E Smart; Isabella R Willcocks; Peter A Holmans; Charlotte A Dennison; Amy J Lynham; Sophie E Legge; Bernhard T Baune; Tim B Bigdeli; Murray J Cairns; Aiden Corvin; Ayman H Fanous; Josef Frank; Brian Kelly; Andrew McQuillin; Ingrid Melle; Preben B Mortensen; Bryan J Mowry; Carlos N Pato; Sathish Periyasamy; Marcella Rietschel; Dan Rujescu; Carmen Simonsen; David St Clair; Paul Tooney; Jing Qin Wu; Ole A Andreassen; Kaarina Kowalec; Patrick F Sullivan; Robin M Murray; Michael J Owen; James H MacCabe; Michael C O'Donovan; James T R Walters; Olesya Ajnakina; Luis Alameda; Thomas R E Barnes; Domenico Berardi; Elena Bonora; Sara Camporesi; Martine Cleusix; Philippe Conus; Benedicto Crespo-Facorro; Giuseppe D'Andrea; Arsime Demjaha; Kim Q Do; Gillian A Doody; Chin B Eap; Aziz Ferchiou; Marta Di Forti; Lorenzo Guidi; Lina Homman; Raoul Jenni; Eileen M Joyce; Laura Kassoumeri; Inès Khadimallah; Ornella Lastrina; Roberto Muratori; Handan Noyan; Francis A O'Neill; Baptiste Pignon; Romeo Restellini; Jean-Romain Richard; Franck Schürhoff; Filip Španiel; Andrei Szöke; Ilaria Tarricone; Andrea Tortelli; Alp Üçok; Javier Vázquez-Bourgon
Journal:  JAMA Psychiatry       Date:  2022-03-01       Impact factor: 25.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.